Five Prime Therapeutics to Present at the Barclays Global Healthcare Conference

SOUTH SAN FRANCISCO, Calif., March 5, 2015 (GLOBE NEWSWIRE) -- Five Prime Therapeutics, Inc. (Nasdaq: FPRX) (Five Prime), a clinical-stage biotechnology company focused on discovering and developing novel protein therapeutics for cancer and inflammatory diseases, today announced that Julie Hambleton, M.D., Chief Medical Officer, will present at the Barclays Global Healthcare Conference on Thursday, March 12, 2015 at 1:05 PM Eastern Daylight Time. The conference will take place at the Loews Miami Beach Hotel.

The live webcast will be accessible at http://investor.fiveprime.com/events.cfm or directly at http://cc.talkpoint.com/barc002/031015a_ae/?entity=122_LKLDXEL. Five Prime will maintain an archived replay of the webcast on its website for 30 days after the conference.

About Five Prime

Five Prime Therapeutics, Inc. discovers and develops innovative therapeutics to improve the lives of patients with serious diseases. Five Prime's comprehensive discovery platform, which encompasses virtually every medically relevant extracellular protein, positions it to explore pathways in cancer, inflammation and their intersection in immuno-oncology, an area with significant therapeutic potential and a growing focus of the company's R&D activities. Five Prime has entered into strategic collaborations with leading global pharmaceutical companies and has promising product candidates in clinical and late preclinical development. For more information, please visit www.fiveprime.com.

CONTACT: Amy Kendall,
         Corporate Communications
         415-365-5776
         [email protected]

You May Also Be Interested In

• PITAKA Marks Its Next Chapter in Berlin With "Signals in the Wind," Unveiling New iPhone 18 Accessories
• Cool Roofs Inc. Targets San Antonio Heat With Reflective Roofing
• Tuya Smart Unveils Doova at IFA 2026, an AI Home Companion Robot Designed to Support Independently Living Seniors